Miguel Forte is the Chief Executive Officer of Zelluna Immunotherapy and currently Chief Commercialization Officer and Chair of the Commercialization Committee, International Society of Cellular Therapy.

Notably, he contributed to TxCell’s transformation from a science based organization into a quoted cell therapy company, participating in several rounds of investment including the IPO of TxCell in 2014, and led multiple discussions, implementations and executions around major commercial and scientific partnerships.